2 active not recruiting, 1 completed, 1 terminated. 1 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Terminated 1 |
| Phase 1 | 1 | Active not recruiting 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Bryan Allen: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma Ferumoxytol injection, Pharmacological ascorbate, External beam radiation therapy - Glioblastoma, Glioblastoma Multiforme | Phase 1 | Active not recruiting | Bryan Allen | 16 | 2023-02-28 | 2026-07-20 |
| T2* MRI Analysis for Sarcoma T2* Imaging - Radiotherapy, Magnetic Resonance Imaging | Completed | Bryan Allen | 8 | 2018-09-18 | 2025-02-21 | |
| A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme Temozolomide, radiation therapy, Ascorbic Acid - Glioblastoma Multiforme | Phase 2 | Active not recruiting | Bryan Allen | 90 | 2017-03-13 | 2026-09-30 |
| Ketogenic Diet Phase 1 for Head & Neck Cancer Ketogenic diet, External beam radiation therapy - Head and Neck Neoplasms | Not applicable | Terminated | Bryan Allen | 14 | 2014-01-01 | 2018-06-26 |
Glioblastoma (2) · Head and Neck Neoplasms (1) · Sarcoma (1) · Squamous Cell Carcinoma of Head and Neck (1)
Radiotherapy (3) · Ascorbic Acid (2) · Temozolomide (2) · Diet, Ketogenic (1) · Ferrosoferric Oxide (1) · Magnetic Resonance Imaging (1) · Magnetic Resonance Myelography (1) · Radiotherapy, Intensity-Modulated (1)
United States (4)
Bryan G. Allen, MD, PhD (2) · John M. Buatti, MD (1)
P30CA086862 (2), R21CA270742 (1)